PMID: 490691Oct 1, 1979Paper

Aspergillus infection of the burn wound

The Journal of Trauma
H H StoneJ E McGowan

Abstract

During a 15-year period, 18 patients with major burns developed a wound infection due to Aspergillus. Ages averaged 28 years, extents of burn were 54% (14-97%) BSA for total surface involvement and 42% (14-85%) BSA for full-thickness injury. Pseudomonas sepsis preceded Aspergillus infection in 16 cases. Thirteen of the episodes occurred in three epidemics, each apparently related to contaminated air-conditioner ducts and filters. Treatment was based upon wound excision in all 18 patients, with recurrence initially in each. Topical and parenteral antifungal agents were never individually successful in controlling the infection. Whenever fungal sepsis involved an extremity alone and thus amputation could rid the body of the entire infected site, survival could then be achieved. The overall mortality rate was 78%. Protection of the wound from Aspergillus colonization appeared to be the only reliable method of preventing this often lethal fungus infection.

Citations

Feb 1, 1995·Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [et Al.]·L Glorioso, G F Webster
Jan 1, 1988·The American Review of Respiratory Disease·J M SametJ D Spengler
Feb 16, 2011·Indian Journal of Plastic Surgery : Official Publication of the Association of Plastic Surgeons of India·Malini R CapoorRavi Prakash Narayanan
Jan 12, 2000·Burns : Journal of the International Society for Burn Injuries·G WilliamsJ D Frame
Sep 25, 1999·Burns : Journal of the International Society for Burn Injuries·J P BarretM H Desai
Apr 20, 1999·Burns : Journal of the International Society for Burn Injuries·H A MousaD A Hassan
Apr 1, 1989·Mycopathologia·R C SummerbellJ Kane
Nov 1, 1992·Diagnostic Microbiology and Infectious Disease·M P PláE Bouza
Apr 28, 2007·Digestive Diseases and Sciences·Josef RiederHugo Bonatti
May 1, 1989·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·G P Bodey, S Vartivarian
Oct 23, 2010·Revue des maladies respiratoires·J-P GangneuxB Philippe
Nov 20, 1998·The Journal of Infection·A ChakrabartiV K Sakhuja
Jul 31, 2003·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Francesco G De RosaDonald E Craven
Feb 1, 1986·Journal of Medical and Veterinary Mycology : Bi-monthly Publication of the International Society for Human and Animal Mycology·M R McGinnisM N Goodwin
Jun 30, 2016·Journal of Burn Care & Research : Official Publication of the American Burn Association·Kevin N FosterDaniel M Caruso
Sep 10, 2008·Drugs·Maria J G T RüpingOliver A Cornely
Jul 1, 1989·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·L L KlimowskiK M Cummings
Apr 15, 2006·Clinical Microbiology Reviews·Deirdre ChurchRobert Lindsay
May 30, 2020·Surgical Infections·Kathryn LagoDana Blyth
Oct 17, 1998·Journal of Clinical Microbiology·J A van BurikD H Spach

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Aspergillosis

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.

Aspergillosis (ASM)

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.

Related Papers

Acta Chirurgica Scandinavica
G Dale, K Solheim
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
V PintadoA Guerrero
© 2021 Meta ULC. All rights reserved